Day: August 5, 2025

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the Canaccord 45th Annual Growth Conference and host 1×1 investor meetings. Date: August 12th, 2025Time of Presentation: 3:30pm ET Location: Boston, MAFormat: Presentation 1×1 Meetings: Please contact your Canaccord representative A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link. About CleneClene Inc.,...

MORRISVILLE, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A rebroadcast of the event will be available and archived for a period of one year at the same location. About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans...

Continued progress positions Company to report topline data for Phase 1 clinical trial of SENTI-202 before year-end SOUTH SAN FRANCISCO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced it has confirmed the recommended Phase 2 dose (RP2D) in its Phase 1 study of SENTI-202, the Company’s potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy, in development for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia (AML). The Phase 1 clinical trial of SENTI-202 is enrolling adult patients with relapsed or refractory (“R/R)...

MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Tuesday, August 12, 2025, at 8:00 a.m. ET to discuss its fiscal 2025 third quarter financial results and to provide a business update. The audio webcast will be accessible under the Home page and Investors page of the Company’s website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru Inc. call. An archived version of the audio webcast will be available for replay on the Company’s website for approximately three months. A telephonic...

Partnership brings autonomous content creation and cross-channel media optimization to NewsOut’s client base NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc. (OTCQB: MOBQ), a leading provider of data-intelligence and advertising technology solutions, and NewsOut, an AI-powered video press-release and media-amplification platform, today announced that NewsOut will integrate Mobiquity’s newly launched CMOne platform. The collaboration deepens NewsOut’s use of artificial intelligence and expands its ability to automate brand storytelling, scale content creation and optimize paid media for clients across North America. The agreement builds upon NewsOut’s recently announced distribution partnership with New to The Street, the nationally syndicated business TV brand with a 3.1-million-subscriber YouTube channel....

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware, and services, is pleased to announce a significant new partnership with Jenningsbet the largest independent retail bookmaker in the UK with nearly 200 licensed betting shops. A family-owned business originally established in 1961, Jenningsbet has built a reputation for integrity and excellence in the industry. Inspired has secured a five-year contract to supply its market-leading Vantage terminal to approximately 144 Jenningsbet shops, totaling around 570 terminals. The rollout is scheduled to commence in Q4 2025. Brooks Pierce, President and CEO of Inspired Entertainment, said, “We are delighted and privileged to have secured Jenningsbet, the largest...

COLUMBUS, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) — Worthington Enterprises (NYSE: WOR), a designer and manufacturer of market-leading brands that improve everyday life by elevating spaces and experiences, today announced that President and Chief Executive Officer Joe Hayek and Chief Financial Officer Colin Souza will participate in a fireside chat as part of next week’s Canaccord Genuity 45th Annual Growth Conference. Brian C. McNamara, CFA, Canaccord Genuity, will facilitate the discussion Tuesday, August 12 at 3:30 p.m. ET. Hayek and Souza will share their insights on the Company’s strategies for accelerating long-term growth and shareholder value through the lens of the proven Worthington Business System of innovation, transformation and M&A. Please use this link to register. A replay will be posted to the Investor Relations...

Salt Lake City, Utah, Aug. 05, 2025 (GLOBE NEWSWIRE) — TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, announced today that it was notified by Nasdaq’s Hearing Panel that it has regained compliance with Nasdaq’s listing rules, subject to Nasdaq Mandatory Panel Monitor for a period of one year. Chief Executive Officer and Director Chris Jones said, “We are very pleased to receive notice from the Nasdaq Hearing Panel that we have regained compliance with all Nasdaq listing requirements. I also would like to thank our employees, external advisors and attorneys for helping us successfully navigate this challenging period in the Company’s history. We look forward to sharing our operating results in the near future.”   Disclaimer on Forward Looking Statements This news release...

Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern Time CARMEL, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its second quarter 2025, for the period ended June 30, 2025, on Tuesday, August 12, 2025, before market open. The Company has scheduled a conference call for the same day, Tuesday, August 12, 2025, at 9:00 am ET to review the results. Conference Call Details Date and Time: Tuesday, August 12, 2024, at 9:00am ET Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor...

Geneva, Switzerland, Aug. 05, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a global leader in semiconductors, Public Key Infrastructure (PKI), and post-quantum technology, celebrates 26 years of innovation since its founding in 1999, having secured over 1.75 billion devices worldwide with its secure chips since its inception. This milestone reaffirms SEALSQ’s position as a trusted cybersecurity provider and highlights its emergence as a leading player in the semiconductor space with a growing portfolio of quantum-resistant chips, including the QS7001 open hardware platform and the QVault TPM Lite scheduled to be certified in May 2026. Today, SEALSQ also shared an update on the certification roadmap for its post-quantum (PQ) chips, reinforcing its leadership in future-proof security. A Legacy of...